Tobacco Harm Reduction
Cigarette smoking remains the leading cause of preventable premature death and disease. From conventional cigarettes to non-combustible alternatives, at ABF we help to understand the continuum of risk associated with nicotine-containing products. Our validated bioanalytical methods provide reliable data for regulatory submissions.
Our Commitment
Extensive expertise in the analysis of biological samples for both clinical and non-clinical studies
Uncompromising Quality, Compliance, and Data Integrity
Timely and Accurate Analysis & Reporting Supporting Decision-Making and Research Efforts
Expert Bioanalytic Services for Regulated Biomarker Studies
Nicotine Pharmacokinetic Analysis for Regulatory Submissions
Trusted Bioanalytical Services Tailored to Your Specific Application
Integrated Solutions for Seamless Sample Management World Wide
Do you have any questions about our services?
We would be happy to advise and support you with your project or your study. Send us your request and tell us your specific wishes.
Pioneers in biomarker research
Almost all of the biomarker methods developed at ABF were published in peer-reviewed journals, a fact that supports the validity, transparency and scientific evidence of the bioanalysis especially of importance for regulatory submissions